Maven Securities LTD Humacyte, Inc. Transaction History

Maven Securities LTD

  • $1.61 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$4.65 - $7.4 $930,000 - $1.48 Million
-200,000 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$7.25 - $11.6 $2.18 Million - $3.48 Million
-300,000 Reduced 60.0%
200,000 $1.45 Million
Q3 2021

Nov 15, 2021
BUY
$9.21 - $16.99 $4.61 Million - $8.5 Million
500,000 New
500,000 $5.81 Million

Others Institutions Holding HUMA

# of Institutions
100
Shares Held
23.1M
Call Options Held
67.8K
Put Options Held
198K
View Full List

About Humacyte, Inc.

HUMA Quotes by TradingView
  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $584M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email